Genetic screening for pheochromocytoma: should SDHC gene analysis be included?
Open Access
- 11 May 2007
- journal article
- case report
- Published by BMJ in Journal of Medical Genetics
- Vol. 44 (9) , 586-587
- https://doi.org/10.1136/jmg.2007.051045
Abstract
PGL3 syndrome is caused by mutations in the SDHC gene. At present, only a few families affected by SDHC mutations have been reported in the literature and in each of them the clinical presentation was characterised by paragangliomas located only in the head and neck regions. No evidence of thoracic or abdominal catecholamine-secreting chromaffin tumours has been reported to date. We report the case of a 15-year-old girl with hypertension and a norepinephrine-secreting abdominal paraganglioma who was found to harbour a novel nonsense SDHC mutation, demonstrating that the clinical presentation of PGL3 syndrome can be more diverse than expected.Keywords
This publication has 6 references indexed in Scilit:
- Phaeochromocytoma, new genes and screening strategiesClinical Endocrinology, 2006
- Predictors and Prevalence of Paraganglioma Syndrome Associated With Mutations of the SDHC GeneJAMA, 2005
- Phenotype variability of neural crest derived tumours in six Italian families segregating the same founder SDHD mutation Q109XJournal of Medical Genetics, 2005
- Germ-Line Mutations in Nonsyndromic PheochromocytomaNew England Journal of Medicine, 2002
- Gene Mutations in the Succinate Dehydrogenase Subunit SDHB Cause Susceptibility to Familial Pheochromocytoma and to Familial ParagangliomaAmerican Journal of Human Genetics, 2001
- Mutations in SDHD , a Mitochondrial Complex II Gene, in Hereditary ParagangliomaScience, 2000